Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 13;16(1):754-768.
doi: 10.1515/med-2021-0282. eCollection 2021.

Breast cancer recurrence prediction with ensemble methods and cost-sensitive learning

Affiliations

Breast cancer recurrence prediction with ensemble methods and cost-sensitive learning

Pei-Tse Yang et al. Open Med (Wars). .

Abstract

Breast cancer is one of the most common cancers in women all over the world. Due to the improvement of medical treatments, most of the breast cancer patients would be in remission. However, the patients have to face the next challenge, the recurrence of breast cancer which may cause more severe effects, and even death. The prediction of breast cancer recurrence is crucial for reducing mortality. This paper proposes a prediction model for the recurrence of breast cancer based on clinical nominal and numeric features. In this study, our data consist of 1,061 patients from Breast Cancer Registry from Shin Kong Wu Ho-Su Memorial Hospital between 2011 and 2016, in which 37 records are denoted as breast cancer recurrence. Each record has 85 features. Our approach consists of three stages. First, we perform data preprocessing and feature selection techniques to consolidate the dataset. Among all features, six features are identified for further processing in the following stages. Next, we apply resampling techniques to resolve the issue of class imbalance. Finally, we construct two classifiers, AdaBoost and cost-sensitive learning, to predict the risk of recurrence and carry out the performance evaluation in three-fold cross-validation. By applying the AdaBoost method, we achieve accuracy of 0.973 and sensitivity of 0.675. By combining the AdaBoost and cost-sensitive method of our model, we achieve a reasonable accuracy of 0.468 and substantially high sensitivity of 0.947 which guarantee almost no false dismissal. Our model can be used as a supporting tool in the setting and evaluation of the follow-up visit for early intervention and more advanced treatments to lower cancer mortality.

Keywords: AdaBoost; classification; cost-sensitive method; machine learning; recurrent breast cancer.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
The approach and the process flow of our system architecture.

Similar articles

Cited by

References

    1. World Health Organization. WHO position paper on mammography screening [Internet]. Switzerland: World Health Organization; 2014. Available From: https://apps.who.int/iris/handle/10665/137339
    2. World Health Organization. WHO position paper on mammography screening [Internet] Switzerland: World Health Organization; 2014. Available From: https://apps.who.int/iris/handle/10665/137339.
    1. American Cancer Society. Cancer facts & figures 2020 [Internet]. Atlanta: American Cancer Society; 2020. Available From: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-...
    2. American Cancer Society. Cancer facts & figures 2020 [Internet] Atlanta: American Cancer Society; 2020. Available From: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-....
    1. Kim J, Shin H. Breast cancer survivability prediction using labeled, unlabeled, and pseudo-labeled patient data. J Am Med Inf Assoc. 2013;20(4):613–8. 10.1136/amiajnl-2012-001570. PubMed PMID: 23467471; PubMed Central PMCID: PMC3721173. - DOI - PMC - PubMed
    2. Kim J, Shin H. Breast cancer survivability prediction using labeled, unlabeled, and pseudo-labeled patient data. J Am Med Inf Assoc. 2013;20(4):613–8. doi: 10.1136/amiajnl-2012-001570. PubMed PMID: 23467471; PubMed Central PMCID: PMC3721173. - DOI - PMC - PubMed
    1. Hsu JL, Hung PC, Lin HY, Hsieh CH. Applying under-sampling techniques and cost-sensitive learning methods on risk assessment of breast cancer. J Med Syst. 2015 Apr;39(4):1–3. 10.1007/s10916-015-0210-x. PubMed PMID: 25712814. - DOI - PubMed
    2. Hsu JL, Hung PC, Lin HY, Hsieh CH. Applying under-sampling techniques and cost-sensitive learning methods on risk assessment of breast cancer. J Med Syst. 2015 Apr;39(4):1–3. doi: 10.1007/s10916-015-0210-x. PubMed PMID: 25712814. - DOI - PubMed
    1. Seely JM, Alhassan T. Screening for breast cancer in 2018-what should we be doing today? Curr Oncol. 2018 Jun;25(Suppl 1):S115–24. 10.374/co.25.3770. PubMed PMID:29910654; PubMed Central PMCID: PMC6001765. - DOI - PMC - PubMed
    2. Seely JM, Alhassan T.. Screening for breast cancer in 2018-what should we be doing today? Curr Oncol. 2018 Jun;25(Suppl 1):S115–24. doi: 10.374/co.25.3770. PubMed PMID:29910654; PubMed Central PMCID: PMC6001765. - DOI - PMC - PubMed

LinkOut - more resources